First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study

JOSEPH SGOUROS; GERASIMOS ARAVANTINOS; GEORGIA-ANGELIKI KOLIOU; GEORGE PENTHEROUDAKIS; FLORA ZAGOURI; AMANDA PSYRRI; DIMITRA IOANNA LAMPROPOULOU; STAMATINA DEMIRI; DIMITRIOS PECTASIDES; EVANGELIA RAZIS; GEORGE FOUNTZILAS; EPAMINONTAS SAMANTAS

doi:10.21873/anticanres.14026

Research ArticleClinical Studies

First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study

JOSEPH SGOUROS, GERASIMOS ARAVANTINOS, GEORGIA-ANGELIKI KOLIOU, GEORGE PENTHEROUDAKIS, FLORA ZAGOURI, AMANDA PSYRRI, DIMITRA IOANNA LAMPROPOULOU, STAMATINA DEMIRI, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GEORGE FOUNTZILAS and EPAMINONTAS SAMANTAS

Anticancer Research February 2020, 40 (2) 929-938; DOI: https://doi.org/10.21873/anticanres.14026

JOSEPH SGOUROS

1Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: josephsgouros@yahoo.co.uk

GERASIMOS ARAVANTINOS

2Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

GEORGIA-ANGELIKI KOLIOU

3Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

GEORGE PENTHEROUDAKIS

4Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Greece

5Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

FLORA ZAGOURI

6Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

AMANDA PSYRRI

7Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DIMITRA IOANNA LAMPROPOULOU

2Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

STAMATINA DEMIRI

8Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DIMITRIOS PECTASIDES

9Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

EVANGELIA RAZIS

10Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

GEORGE FOUNTZILAS

11Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece

12Aristotle University of Thessaloniki, Thessaloniki, Greece

13German Oncology Center, Limassol, Cyprus

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

EPAMINONTAS SAMANTAS

1Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

PreviousNext

In this issue

Anticancer Research

Vol. 40, Issue 2

February 2020

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 11 + 5 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.